Startseite>>Lipids>> Glycerophospholipids>>1-Palmitoyl-2-Arachidonoyl-sn-glycero-3-PE

1-Palmitoyl-2-Arachidonoyl-sn-glycero-3-PE (Synonyms: 1-Hexadecanoyl-2-Eicosatetraenoyl-sn-glycero-3-Phosphatidylethanolamine, 1-Hexadecanoyl-2-Eicosatetraenoyl-sn-glycero-3-Phosphoethanolamine, 1-Palmitoyl-2-arachidonoyl PE, PAPE, PE(16:0/20:4), 16:0/20:4-PE)

Katalog-Nr.GC46487

A phospholipid

Products are for research use only. Not for human use. We do not sell to patients.

1-Palmitoyl-2-Arachidonoyl-sn-glycero-3-PE Chemische Struktur

Cas No.: 70812-59-8

Größe Preis Lagerbestand Menge
5 mg
153,00 $
Auf Lager
10 mg
274,00 $
Auf Lager
25 mg
648,00 $
Auf Lager
50 mg
1.221,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

1-Palmitoyl-2-arachidonoyl-sn-glycero-3-PE is a phospholipid that contains palmitic acid and arachidonic acid at the sn-1 and sn-2 positions, respectively. It has been found in egg yolk and isolated rat retina.1,2

1.Sun, N., Chen, J., Bao, Z., et al.Egg yolk phosphatidylethanolamine: Extraction optimization, antioxidative activity, and molecular structure profilingJ. Food Sci.84(5)1002-1011(2019) 2.Gugiu, B.G., Mesaros, C.A., Sun, M., et al.Identification of oxidatively truncated ethanolamine phospholipids in retina and their generation from polyunsaturated phosphatidylethanolaminesChem. Res. Toxicol.19(2)262-271(2006)

Bewertungen

Review for 1-Palmitoyl-2-Arachidonoyl-sn-glycero-3-PE

Average Rating: 5 ★★★★★ (Based on Reviews and 15 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 1-Palmitoyl-2-Arachidonoyl-sn-glycero-3-PE

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.